Sun.Jul 07, 2024

article thumbnail

Four drugmakers found to have breached ABPI code

pharmaphorum

Novartis, Pfizer, Otsuka and Novo Nordisk have been called out for breaching the ABPI code of practice

115
115
article thumbnail

Wellbutrin XL Versus Bupropion SR – Insomnia Rates

Med Ed 101

JS is a 45 year-old male who has been taking bupropion SR 150 mg twice daily for about 4 weeks. He has been taking it for depression. He reports that depressive symptoms have started to improve but he does notice that he has a harder time getting to sleep and staying asleep since beginning the […] The post Wellbutrin XL Versus Bupropion SR – Insomnia Rates appeared first on Med Ed 101.

105
105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The business development landscape of VMS in Pharma: India – Asia Perspective

Express Pharma

Season 2 of the Express Pharma – Nutrify Today Boardroom series presents key dialogues from the Nutrify C Suite Sumflex 2024, held over June 6-7, 2024. In this video, industry leaders dissect the trends impacting the Vitamins, Minerals and Supplements (VMS) segment in India’s Pharma market, ranging from the focus shift from illness to wellness, emerging segments like sports nutrition, sleep products, increasing regulator oversight requiring evidence based nutraceuticals, and future innovat

102
102
article thumbnail

Less than Meets the Eye: LDT Small Entity Compliance Guide Adds Little Insight

FDA Law Blog: Biosimilars

By Gail H. Javitt — In its final rule on laboratory developed tests (LDTs) (see our prior blog here ), FDA acknowledged that “some laboratories may lack familiarity, experience, or existing infrastructure for complying with FDA requirements” and made multiple references to a “small entity compliance guidance” that the agency intended to publish to “provide additional guidance to small businesses.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Which pharmaceutical drugs have the most drug patents in France?

Drug Patent Watch

This chart shows the drugs with the most patents in France. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

59
article thumbnail

Episode 937: Is your micro lab hiding susceptibility data from you?

Pharmacy Joe

In this episode, I’ll discuss the suppression of antimicrobial susceptibility results. Episode 937: Is your micro lab hiding susceptibility data from you? Subscribe on iTunes , Android , or Stitcher When a hospital microbiology laboratory performs antimicrobial susceptibility testing using microdilution or disk diffusion methods, not all of the results are presented to clinicians in the medical record.

article thumbnail

Bulevirtide in Combination With PegInterferon Results In Undetectable Hepatitis D RNA Post-Treatment

Pharmacy Times

In the 2 mg bulevirtide (Gilead Sciences) group, 44% of individuals achieved HDV RNA that was undetectable compared with 70% in the 10 mg group.

37